For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Mexiletine hydrochloride - Arrhythmias
PAD Profile : Mexiletine hydrochloride - Arrhythmias
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Amiodarone hydrochloride
- Flecainide acetate
- Propafenone hydrochloride
- Digoxin
- Sotalol hydrochloride
- Atenolol
- Bisoprolol fumarate
- Disopyramide
- Lidocaine
- Metoprolol tartrate
- Procainamide hydrochloride
- Propranolol hydrochloride
- Verapamil hydrochloride
Other Indications
Additional Documents
Committee Recommendations
The Surrey Heartlands Integrated Care System Area Prescribing Committee approves the prescribing of mexiletine for the management of drug resistant ventricular arrhythmia when initiated and continued by a specialist.
The APC recommend a RED traffic light status for the use of mexiletine for this indication.
All patients currently being prescribed mexiletine in primary care should be referred into a cardiologist for specialist review. Responsibility for prescribing must remain with the specialist.
Patients currently prescribed Namuscla® for the management of drug resistant arrhythmias should be reviewed by specialists to consider switching to the products licensed for ventricular arrhythmias noting that there isn’t an exact equivalent dose.